1. Home
  2. CNET vs OGEN Comparison

CNET vs OGEN Comparison

Compare CNET & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZW Data Action Technologies Inc.

CNET

ZW Data Action Technologies Inc.

HOLD

Current Price

$1.29

Market Cap

4.0M

ML Signal

HOLD

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$1.00

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNET
OGEN
Founded
2003
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CNET
OGEN
Price
$1.29
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.7K
52.7K
Earning Date
11-14-2025
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,166,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$0.74
52 Week High
$2.78
$18.90

Technical Indicators

Market Signals
Indicator
CNET
OGEN
Relative Strength Index (RSI) 44.11 63.01
Support Level $1.22 $0.88
Resistance Level $1.37 $0.91
Average True Range (ATR) 0.07 0.05
MACD 0.02 0.02
Stochastic Oscillator 31.72 86.44

Price Performance

Historical Comparison
CNET
OGEN

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: